Become a Member
TAKING A COURSE ON E-CAMPUS? LOGIN HERE

Inflammatory Bowel Disease and Workplace Disability – What Employers and Employees Should Know

Free 1 Hour
Ulcerative Colitis and Crohn’s Disease are similar illnesses and are often referred to together as Inflammatory Bowel Disease (IBD). These conditions are life-long and may flare up unpredictably. However, many people with IBD will have long periods when they have few or no symptoms at all. People with Inflammatory Bowel Disease want to work, and in many cases have the health to work, however a range of factors can cause barriers to managing their IBD at work.

Watch this free webinar to get a taste of how we teach

Register Now

Want To Get Accreditation For This Webinar?

Become A Member

This webinar will present current research evidence on the impacts of IBD on work abilities and the types of resources that employees are seeking to assist them in maintaining employment despite their chronic disease.

Take-home messages

  • IBD patients have an increased frequency of sick leave, disability pension, and unemployment compared to the general population.
  • Up to 90% of IBD patients require accommodations but as many as two-thirds are not able to make work adjustments to avoid taking time off.
  • Perhaps the most common accommodations most required are access to a toilet or toilet breaks and time off to attend medical appointments.
  • Examples of good resources for employees and employers are available on the Crohn’s and Colitis United Kingdom website.

Learning Outcomes

To appreciate the impact of IBD on employment and understand the workplace challenges faced by workers with IBD
About the accommodations and strategies IBD patients have used for overcoming workplace disability.
What resources are already available for employees and employers and what resources should be made available in the future.

Discover the Work Wellness Institute Membership!

Our annual membership unlocks unlimited accreditation

Become a Member

Stay in the Loop

Keep up to date with our latest news and analysis by subscribing to our regular newsletter